SavedAdd your journal

Journals / Klinik Psikofarmakoloji Bülteni / 2015 / Cilt: 25 - Sayı: 2

Escitalopram-Induced Bradycardia in Elderly Individuals: A Case Series Report

Betül ÖZDİLEK
Pages
183–185
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clinicians should be cautious about cardiac effects when using a selective serotonin reuptake inhibitor in elderly people, even at a low dose.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The authors report on three elderly patients treated with escitalopram, 10 mg/day, who presented with marked sinus bradycardia.
📊
Key Findings & Data:The bradycardia was clinically symptomatic or asymptomatic and disappeared within 24 hours after escitalopram was discontinued.
💡
Conclusion & Impact:Clinicians should be cautious about cardiac effects when using a selective serotonin reuptake inhibitor in elderly people, even at a low dose.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The authors report on three elderly patients treated with escitalopram, 10 mg/day, who presented with marked sinus bradycardia. The bradycardia was clinically symptomatic or asymptomatic and disappeared within 24 hours after escitalopram was discontinued. Clinicians should be cautious about cardiac effects when using a selective serotonin reuptake inhibitor in elderly people, even at a low dose.

🔖

Cite This Article

ÖZDİLEK, B. (2022). Escitalopram-Induced Bradycardia in Elderly Individuals: A Case Series Report. Klinik Psikofarmakoloji Bülteni, Cilt: 25 - Sayı: 2, 183–185. https://ajindex.com/articles/573941

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry 1998;59(Suppl 15):42-8
  2. Olsen DG, Dart RC, Robinett M. Severe serotonin syndrome from escitalopram overdose [abstract]. Clin Toxicol 2004;42:744
  3. Isbister GK, Bowe SJ, Dawson A, et al. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004;42(3):277-85. [CrossRef] 4. Scharko AM, Schumacher J. Prolonged QTc interval in a 14-year-old girl with escitalopram overdose. J Child Adolesc Psychopharmacol 2008;18(3):297-8. [CrossRef] 5. Yuksel FV, Tuzer V, Goka E. Escitalopram intoxication. Eur Psychiatry 2005;20(1):82. [CrossRef] 6. Baranchuk A, Simpson CS, Methot M, et al. Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines. Can J Cardiol 2008;24(7):e38-e40. [CrossRef] 7. Huska MT, Catalano G, Catalano MC. Serotonin syndrome associated with the use of escitalopram. CNS Spectr 2007;12(4):270-4
  4. Forrester MB. Escitalopram ingestions reported to Texas poison control centers, 2002-2005. Hum Exp Toxicol 2007;26(6):473-82. [CrossRef] 9. Beyenburg S, Schönegger K. Severe Bradycardia in a Stroke Patient Caused by a Single Low Dose of Escitalopram. Eur Neurol 2007;57(1):50-1. [CrossRef] 10. van Gorp F, Whyte IM, Isbister GK. Clinical and ECG Effects of Escitalopram Overdose. Ann Emerg Med 2009;54(3):404-8. [CrossRef] 11. Chan A, Isbister GK, Kirkpatrick CM, et al. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM 2007;100(10):609-15. [CrossRef] 12. Isbister GK, Friberg LE, Stokes B, et al. Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Ann Emerg Med 2007;50(5):593-600. [CrossRef] 13. Friberg LE, Isbister GK, Duffull SB. Pharmacokinetic pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. Br J Clin Pharmacol 2006;61(2):177-90. [CrossRef] 14. Kurdyak PA, Manno M, Gomes T, et al. Antidepressants, metoprolol and the risk of bradycardia. Ther Adv Psychopharmacol 2012;2(2):43-9. [CrossRef]